We won’t stop until we’ve eradicated HIV/AIDS
Clinical Research Expertise
Turning promising ideas into new treatments that benefit HIV patients is our goal. AIDS Research Alliance has been at the forefront of HIV clinical research since 1989, participating in the development of half of the anti-HIV drugs available today. Our work has helped to make HIV/AIDS treatable, saving millions of lives across the globe.
We are leaders in vaccine, microbicide, and antiretroviral research, participating in over 120 clinical trials, including every major HIV vaccine trial conducted in the U.S. We are proud of our ability to recruit study volunteers from vulnerable populations. We believe the populations hardest hit by AIDS will benefit most from our work.
Founded to speed the pace of HIV research, AIDS Research Alliance has a track record of completing over 90% of our trials on time and on budget. This is why major universities, pharmaceutical companies, and clinical research organizations choose AIDS Research Alliance as an investigational research site.
We have a dedicated staff of experienced professionals who consistently produce accurate results for our study sponsors. In addition, AIDS Research Alliance uses the most advanced clinical trial management software, and state-of-the-art equipment so that we can conduct our trials with maximum efficiency.
AIDS Research Alliance maintains its own Institutional Review Board (IRB) [Federal Wide Assurance Number: FWA00000941], whose sole responsibility is to protect the rights of our trial participants. An in-house IRB gives AIDS Research Alliance a strong advantage over other research sites. The IRB approval time at AIDS Research Alliance averages two weeks, and our clinical trials contract review time averages 10 days. A full-time IRB Administrator coordinates all IRB and Institutional BioSafety Committee affairs. As a result, AIDS Research Alliance has the capacity to begin and complete trials faster and more efficiently than any of our competitors.
AIDS Research Alliance’s clinic is a state-of-the-art, CLIA-waived research facility, and one of 18 investigative sites in the United States for the HIV Vaccine Trials Network (HVTN). We have a fulltime, dedicated, experienced clinic staff, who are responsible for the collection, processing, and shipment of all required laboratory tests and specimens, as well as patient retention. Our clinic staff is trained in advanced laboratory techniques, and able to process peripheral blood mononuclear cells (PBMCs). Clinic personnel maintain certifications in Advanced Cardiac Life Support (ACLS), Good Clinical Practices, Responsible Conduct of Research, Blood Borne Pathogens, HIPAA, International Air Transport, and HIV Test Counseling.
Our physicians are experienced in internal medicine, infectious diseases and psychiatry. Our research pharmacists provide clinical pharmacology expertise, operate our research pharmacy, and dispense study medications.
Our staff adheres to the highest industry standards for conducting clinical research. The FDA has randomly audited our laboratory and IRB on several occasions with no findings.
Research Is All We Do
AIDS Research Alliance’s unique, non-profit business model allows us to focus exclusively on your study. Many primary care providers conduct research, but primary care is their top priority. At AIDS Research Alliance, our number one priority is clinical research. Research is what we do. As a result, we are able to focus 100% of our attention on adherence, retention, and protocol compliance. Our non-profit status gives us the freedom and the obligation to pursue the best and brightest ideas without regard to competing priorities.
Using a venue-based recruitment strategy, supported by a health literacy program, our multi-lingual and culturally competent educators use targeted outreach strategies—such as community forums, health fairs, individual counseling, group presentations, and the media—to educate the HIV community and the public about AIDS, HIV prevention, current treatment approaches, medical research, and the importance of clinical trials to scientific progress. Our continuous presence throughout Southern California for more than two decades has enabled AIDS Research Alliance to recruit the most diverse study cohorts ever assembled in the United States.
AIDS Research Alliance is located in Downtown Los Angeles—the most diverse and densely populated area of Southern California. At this location, we are well positioned to recruit the most difficult study populations. We excel in recruiting those who have traditionally been underrepresented in clinical trials, particularly women and minorities. We take pride in knowing that we are among the top sites in the U.S. in the enrollment of African Americans in HIV clinical trials.
In the HIV/AIDS Community
Research at AIDS Research Alliance is supported by a Community Advisory Board (CAB), a group of volunteers who provide input and guidance on potential studies, make recommendations on recruitment and outreach strategies, and provide feedback on our work in the community.
Industry representatives with inquiries are encouraged to contact our Research Pharmacist, Kevin Griggs, PharmD, at email@example.com.